FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
New Clinical Trial Seeks to Slow Progression of Nearsightedness in Children
A new international clinical trial is underway across Europe to test whether low-dose atropine eye drops can effectively slow the progression of [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as our Clinical [...]
New Article on Gabapentin and Tramadol in Paediatric Patients with Chronic Pain
A new article published on 6 October 2023 in the Journal of the British Pharmacological Society titled"Dose rationale for gabapentin and tramadol [...]
CVBF supports the Rare Diseases Day 2023
This 28 February is Rare Diseases Day (RDD), an opportunity to celebrate people living with rare diseases and to raise [...]
Newsletter, FEBRUARY 2023
22nd February 2023 Newsletter February 2023 Clinical research is undergoing a moment of great change due to the increasingly use [...]
The paper on the management of biosample in paediatrics research is finally out
CVBF collaborated with its member Fondazione per la Ricerca Farmacologica “Gianni Benzi” and the European Clinical Research Infrastructure Network (ECRIN) [...]
ICH – Good Clinical Practice (CGP) training course
CVBF’s mission to perform education in clinical expertise comes to life with an online on-demand course on Good Clinical Practice. [...]
2022 starts with three new scientific publications
CVBF is excited to announce that three new research articles counting with the participation of experts from our consortium, were recently published. “Overview of the [...]
CVBF is now a member of the European Open Science Cloud
We are happy to announce that CVBF is now a member of the (EOSC). This will ensure compliance with new Open Science policy in the [...]
EJP RD Training on strategies to foster solutions of undiagnosed rare disease cases
As part of the training activities proposed by EJP RD, an online training course on “Training on strategies to foster solutions of undiagnosed rare disease cases” is being organised by [...]
Task Force on Disregarded Rare Diseases (Pluto Project)
The Therapies Scientific Committee (TSC) of the International Rare Diseases Research Consortium (IRDiRC) is establishing a Task Force to characterize specific commonalities amongst a large group of “disregarded” rare diseases, [...]
Task Force on Drug Repurposing GUIDEBOOK
IRDiRC's Therapies Scientific Committee (TSC) is establishing a Task Force on Drug Repurposing Guidebook aimed at helping developers identify specific tools and practices of relevance for repurposing projects, by focusing on repurposing [...]
New IRDiRC Publication
The International Rare Diseases Research Consortium (IRDiRC) is proud to announce the publication of a commentary on 10 years of progress and challenges of IRDiRC in the prestigious journal Nature [...]












